MARTY E SAWAYA, MD
JERRY SHAPRIO, MD
 
Title:  "Alopecia:  Unapproved Treatments or Indications" 
 
Summary of Article:
 
An in-depth analysis of several "hair loss treatments" which have not been approved by the FDA.
 
The first category is called "Off Label" prescription products to treat hair loss.  Namely Spironolactone (Aldactone) is covered, as is a very comprehensive description of Flutamide, its results in clinical trials and effects on animals, humans, the prostate, and other androgen target tissues.  Flutamide is discussed pertaining to the quality of its antiandrogenic effects.  Within this section is a discussion on
Progesterone, Cyproterone Acetate (another well known antiandrogen in Canada and Europe, but not so well known in the US), and Cimetidine.
 
The second category discussed is about those Over the Counter products that make Antiandrogen *CLAIMS* ...  some examples of the products discussed here are Saw Palmetto and the legitimacy of it in fighting hair loss.
 
Another treatment within this second category of OTC products that make Antiandrogen Claims, is Kevis.  The results of an actual clinical trial on the Kevis product are reviewed here, and the findings may surprise you.  Believe it or not, the efficacy of Fabao 101D is also covered in this article.  Some history on where it came from, what is in it, and whether there have been any trials to prove its efficacy.
 
If you have any questions or curiosities about any of the following products you may have heard about, they are reviewed here with some pretty revealing clinical study information for some of them:  Iamin (Copper), GrafCyte (For use in men who have just had hair transplants - FDA Approved), Polysorbate 80, Folligen, Amino Acids, Biotin, Folic Acid, Pieliel, Viviscal, Aminexil, and ThymuSkin.
 
Lastly, a review of the projects AntiCancer, Inc. is working on can be found in this article, including Genetic Research for Hair Loss and Hair Color.